Compare J & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | J | COO |
|---|---|---|
| Founded | 1947 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Ophthalmic Goods |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.5B | 16.5B |
| IPO Year | 1994 | 1994 |
| Metric | J | COO |
|---|---|---|
| Price | $127.65 | $69.97 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 11 |
| Target Price | ★ $156.60 | $90.18 |
| AVG Volume (30 Days) | 874.5K | ★ 1.9M |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.11% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.12 | 0.66 |
| Revenue | ★ $14,984,646,000.00 | $2,532,800,000.00 |
| Revenue This Year | $13.41 | $6.61 |
| Revenue Next Year | N/A | $5.36 |
| P/E Ratio | $115.45 | ★ $108.37 |
| Revenue Growth | ★ 49.51 | 18.41 |
| 52 Week Low | $106.23 | $61.78 |
| 52 Week High | $168.44 | $89.83 |
| Indicator | J | COO |
|---|---|---|
| Relative Strength Index (RSI) | 37.31 | 19.64 |
| Support Level | $125.17 | $67.78 |
| Resistance Level | $141.38 | $75.25 |
| Average True Range (ATR) | 3.77 | 2.04 |
| MACD | -0.93 | -1.39 |
| Stochastic Oscillator | 6.50 | 0.32 |
Jacobs Solutions is a global provider of engineering, design, procurement, construction, and maintenance services as well as cyber engineering and security solutions. The firm serves industrial, commercial, and government clients in a wide variety of sectors, including water, transportation, healthcare, technology, and chemicals. Jacobs Solutions employs approximately 60,000 workers. The company generated $12 billion in revenue in fiscal 2025.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.